Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 27/12/20131 min de lecture
Withdrawal of Approval of New Animal Drug Applications; Roxarsone
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal approval of five new animal drug applications (NADAs) for roxarsone oral dosage form products at the sponsor's request because the products are no longer manufactured or marketed.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →